Compare Asian CDMOs across India, China, Japan, South Korea, and Southeast Asia. Filter by manufacturing type, regulatory approvals, and capacity for API synthesis, biologics, and drug products.
748 companies listed
Every country below has its own page with a ranked CDMO list, a country-zoomed facilities map, and the local regulatory picture. Counts are live manufacturing-site totals.
Japan
Yuki Gosei Kogyo Co., Ltd. is a Japanese fine chemical manufacturer providing GMP-compliant contract manufacturing of pharmaceutical intermediates, new drugs, and generics. The company has extensive experience in drug development, manufacturing, and commercialization, exporting to more than 30 countries worldwide.
China
Zhejiang Davi Pharmaceutical Co., Ltd., established in 2004, is an exclusively foreign-owned high-tech manufacturer of active pharmaceutical ingredients and intermediates located in Huzhou City, Zhejiang, China. With a total investment of $8M USD and 35,000 m2 floor space, they operate FDA and COS-required GMP workshops. They specialize in folate-related APIs: Methotrexate, Methotrexate Sodium, Calcium Folinate (Leucovorin Calcium), Calcium Levofolinate, and L-5-Methyltetrahydrofolate Calcium. The company is FDA-registered with 3 FEI numbers, has 8 FDA inspections (2 NAI, 6 VAI, 0 OAI), 1 Class II recall, 4 FDA-approved products (tablet, extended-release tablet), and participates at CPHI events globally. They undertake OEM orders for intermediates. Classified as API manufacturer rather than CDMO because they primarily manufacture their own specialty APIs; contract services appear limited to OEM intermediate orders.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.